کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6272292 1614779 2015 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی علوم اعصاب (عمومی)
پیش نمایش صفحه اول مقاله
Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status
چکیده انگلیسی


- We examined EGFR, PTEN and MVP gene dosages in 113 samples from GBM.
- A significant inverse correlation between MVP and PTEN gene copies was determined.
- Lower MVP gene dosages correlated with higher survival of patients with chemotherapy.
- MVP may be a novel and interesting target for new treatments in GBM.

Glioblastoma (GBM) is the most frequent and malignant primary brain tumor. Conventional therapy of surgical removal, radiation and chemotherapy is largely palliative. Major vault protein (MVP), the main component of the vault organelle has been associated with multidrug resistance by reducing cellular accumulation of chemotherapeutic agents. With regard to cancer, MVP has been shown to be overexpressed in drug resistance development and malignant progression.The aim of the present study was to evaluate the MVP gene dosage levels in 113 archival samples from GBM and its correlation with patients' survival and epidermal growth factor receptor (EGFR) and phosphatase and tensin homolog (PTEN) gene dosages. Fluorescent in situ hybridization revealed polysomy of chromosome 7 in 76.1% of the GBMs and EGFR amplification in a 64.6% of the tumors. Genetic status of EGFR, PTEN and MVP copies was determined by multiplex ligation-dependent probe amplification (MLPA) technique. 31% of the tumors showed the EGFR is variant III mutation (EGFRvIII) mutation and 74.3% of them presented amplification of MVP gene. Amplification of EGFR and MVP was found in a 63.7% and 56.6% of the GBM, respectively. An inverse correlation between MVP and PTEN dosage values was observed. Besides, an inverse relationship between the survival of the patients treated with chemotherapy and the levels of MVP copies was determined. In conclusion, our study reveals an important role of MVP, together with EGFRvIII and PTEN, in the progression of GBM and proposes it as a novel and interesting target for new treatment approaches.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Neuroscience - Volume 297, 25 June 2015, Pages 243-251
نویسندگان
, , , , , , , , ,